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Abstract
We have developed an efficient method to quantify cell-to-cell infection with single-cycle, replication dependent reporter
vectors. This system was used to examine the mechanisms of infection with HTLV-1 and HIV-1 vectors in lymphocyte cell
lines. Effector cells transfected with reporter vector, packaging vector, and Env expression plasmid produced virus-like
particles that transduced reporter gene activity into cocultured target cells with zero background. Reporter gene expression
was detected exclusively in target cells and required an Env-expression plasmid and a viral packaging vector, which
provided essential structural and enzymatic proteins for virus replication. Cell-cell fusion did not contribute to infection, as
reporter protein was rarely detected in syncytia. Coculture of transfected Jurkat T cells and target Raji/CD4 B cells enhanced
HIV-1 infection two fold and HTLV-1 infection ten thousand fold in comparison with cell-free infection of Raji/CD4 cells.
Agents that interfere with actin and tubulin polymerization strongly inhibited HTLV-1 and modestly decreased HIV-1 cell-to-
cell infection, an indication that cytoskeletal remodeling was more important for HTLV-1 transmission. Time course studies
showed that HTLV-1 transmission occurred very rapidly after cell mixing, whereas slower kinetics of HIV-1 coculture
infection implies a different mechanism of infectious transmission. HTLV-1 Tax was demonstrated to play an important role
in altering cell-cell interactions that enhance virus infection and replication. Interestingly, superantigen-induced synapses
between Jurkat cells and Raji/CD4 cells did not enhance infection for either HTLV-1 or HIV-1. In general, the dependence on
cell-to-cell infection was determined by the virus, the effector and target cell types, and by the nature of the cell-cell
interaction.
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Introduction
Retroviruses can infect cells as cell-free particles or by cell-to-
cell transmission [1,2,3,4,5]. In the latter route of infection, specific
cell-cell contacts may strongly enhance virus infection by
triggering the reorganization of cytoskeletal and cell-surface
protein networks to focus virus release toward clustered receptors
on an apposed target cell [2,6,7,8,9,10,11,12]. Cell-to-cell
infection would require steps in the virus infectious cycle to be
integrated with events in the cell-cell adhesion process; hence, the
mechanism of cell-to-cell transmission would depend on specific
interactions between cell and virus proteins. HTLV-1 is a highly
cell-associated virus that is most likely disseminated by cell-to-cell
transmission in vivo [13]. Microscopic image analysis of HTLV-1-
infected lymphocytes in close contact with uninfected cells in vitro
showed aggregation and transfer of virus components at a
‘‘virological synapse’’ (VS) [14,15]; whether the transfer of viral
proteins between cells was accompanied by provirus formation is
still unknown. On the other hand, HIV-1 infection has been
studied intensively, and in vitro systems have been used to examine
cell-to-cell transmission of virus from infected T-cells or infected
macrophages to uninfected T-cells and epithelial cells
[2,6,7,8,9,10,11,12,16,17,18], as well as the special situation where
HIV-1 particles are collected on dendritic cells and transmitted to
T-cells via an ‘‘infectious synapse’’ [19,20,21]. MLV has been
shown to move between cells along filipodial bridges that connect
infected and uninfected cells not in immediate proximity [22].
More recently, a variety of cell-cell communicative structures such
as nanotubes, mono- and polysynapses, have been demonstrated
to serve as platforms for directed HIV particle egress, transfer and
endocytosis by target cells [23]. In sum, our knowledge of
retrovirus biology combined with in vitro experimental data
suggests that cell-to-cell transmission is an important mechanism
of virus spread in vivo.
Much of what we know about cell-to-cell infection is inferred
from microscopic image analysis; fluorescent microscopy shows
viral proteins mobilized to cell-cell contact sites and electron
micrographs show virus particles localized between interacting
cells [2,4,10,14,16,24]. Direct evidence for virus replication in the
context of cell-to-cell transmission has been reported for HIV-1 by
measuring reverse transcription products in infected target cells or
by FACS analysis of HIV-1 protein expression in fluorescently
labeled target cells [6,7,11,12,25] or by long-term video
microscopy observation of HIV Gag-iGFP replication [26].
Retroviral vectors, which have greatly facilitated studies of cell-
free infection, are not well suited for examining cell-to-cell
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producer cells generates a strong signal, and because these cells
cannot be removed entirely from newly infected target cells, they
obscure infection events. Clearly, a simple method to quantify cell-
to-cell infection would provide a needed functional complement to
image analysis, and help to define mechanisms of cell-to-cell
infection.
We have solved these technical problems by constructing HIV-1
and HTLV-1 vectors that consist of a virus packaging plasmid, an
Env-expression plasmid, and a replication dependent reporter
vector. The design of the new reporter vectors is based on a
concept described initially by Heidmann et al. [27], which was
later adapted to study retrotransposition of endogenous retrovi-
ruses [28], mammalian LINE1 elements [29], and yeast TY1
elements [30]. We demonstrate here that the new HIV-1 and
HTLV-1 reporter vectors are ideally suited for studying cell-to-cell
infection, as reporter protein expression is confined exclusively to
the infected target cell. By using eYFP based transfer vectors, we
track infected cells that are not multinucleated and thereby rule
out cell fusion as a mechanism of viral transmission. Quantifying
the transduction of the new luciferase based vectors in target cells,
we show the absolute dependence of HTLV-1 transmission on
cell-cell contact, cytoskeleton remodeling and Tax protein
expression, while HIV infection is enhanced twofold in our cell
coculture settings and has characteristics both of cell-free and cell-
to-cell modes of transmission. Induction of an immunological
synapse (IS) between Jurkat effector cells and Raji/CD4 target
cells does not increase infection with either HIV-1 or HTLV-1
VLPs suggesting that cell-to-cell infection requires the formation of
specialized VS.
Results
Quantitation of HTLV-1 and HIV-1 infection in cocultures
of VLP-producer cells and target cells
In order to take advantage of the sensitivity and versatility of
retroviral vectors for studying virus replication, and to overcome
difficulties encountered with standard reporter vectors in coculture
infection experiments, we constructed reporter vectors similar to
those that have been used to study retrotransposition of various
mobile genetic elements [28,29,30]. The new HTLV-1 and HIV-1
reporter vectors contain a reporter gene cassette in antisense
orientation relative to the virus; the reporter gene is interrupted by
an intron, which is oriented in the sense direction (Fig. 1A). The
intron, which can be spliced only from the vector mRNA, prevents
expression of the reporter gene in transfected effector cells
(Fig. 1B). Virus-like particles (VLPs) are produced after transfec-
tion of effector cells with reporter vector and virus packaging
vector. Infection of target cells with VLPs that contain the spliced
reporter vector RNA will generate a provirus that is now capable
of expressing the reporter protein (Figure 1B). HTLV-1 and HIV-
1 reporter vectors were made that encode either luciferase (inLuc)
or yellow fluorescent protein (inYFP) genes. When transfected
alone into 293T cells (not shown) or Jurkat cells (Fig. 2A), the
inLuc vectors did not express detectable levels of luciferase activity.
VLPs produced from cells transfected with either HTLV-1 or
Figure 1. Specialized HTLV-1 and HIV-1 reporter vectors to
measure single-cycle replication in coculture infection. (A)
Replication-dependent HTLV-1 and HIV-1 transfer vectors contain an
antisense-oriented expression cassette, which consists of a CMV
promoter, firefly luciferase (luc) gene, and TK polyA signal (PA). The
luc gene is interrupted by an intron (i), which is oriented in the sense
direction, indicated by splice donor (SD) and splice acceptor (SA) sites.
The HIV1-inLuc vector contains a Rev responsive element (RRE) and
central polypurine tract (cPPT). Analogous vectors were constructed
that contain a yellow fluorescent protein gene with intron (inYFP). (B)
Translation of the reporter protein mRNA (small arrow) in transfected
cells is blocked by the intron. The vector mRNA (large arrow) is spliced
and packaged into VLPs; after infection and replication, a provirus is
formed that lacks the intron and is capable of reporter gene expression.
doi:10.1371/journal.ppat.1000788.g001
Author Summary
Cell-free virus particles released from infected cells can be
transmitted to target cells by diffusion or may be
conveyed directly to target cells via specific intercellular
contacts; the latter is referred to as cell-to-cell infection.
Microscopic imaging has shown how viral proteins and
virus particles move within and between cells, accumulat-
ing at sites of cell-cell contact. While we suspect that these
images represent virus infection, it has been difficult to
accurately quantify virus replication and provirus forma-
tion in most cell-to-cell infection experiments. Retroviral
vectors that encode reporter proteins have been invalu-
able tools for analyzing retrovirus replication and restric-
tion, but they have had limited utility in cell-to-cell
infection studies due to high background noise resulting
from reporter expression in the producer cells. We report
the construction and characterization of retroviral vectors
that express reporter protein exclusively in target cells and
only after completing a full replication cycle. We have
validated this approach and have begun to analyze cell
and virus determinants for cell-to-cell infection with
vectors for two human retroviruses that infect T cells. We
show that the mechanism of transmission and ensuing
virus replication depend on the particular virus, the
effector and target cell types, and on the specific type of
cell-cell interaction.
Cell-to-Cell Infection HTLV-1 HIV-1 inLuc
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imately 35% has no intron (data not shown).
To validate these vectors and to examine the mechanisms of
retrovirus transmission between cells, we developed a model
coculture system with Jurkat T cells as the VLP producers. Jurkat
cells are well characterized, have high transfection efficiency, and
mimic virus-producing T cells. For reasons described below, Raji/
CD4 cells were used as targets [31]. Jurkat cells were transfected
with viral vectors and incubated for 24 h before adding an equal
number of Raji/CD4 target cells and infections were quantitated
by luciferase assay 48 h after the start of coculture. Transduction
of Luc activity was higher with HTLV-1 vectors compared to
HIV-1 vectors (Fig. 2A); this is notable because cell-free infection
with HIV-1 and HTLV-1 VLPs shows the opposite (see below,
section ‘Differences in HTLV-1 and HIV-1 transmission in the
coculture infections’). Transduction of Luc activity was 20-fold to
50-fold lower for both viruses when Raji/CD4 target cells were
absent; i.e. when VLPs were transmitted between Jurkat cells. In
the absence of either an Env expression vector or a viral packaging
plasmid, no reporter gene activity was detected (Fig. 2A). VLP
infectivity required virus budding, as cotransfection of the viral
vectors with a dominant negative VPS4A expression plasmid
inhibited Luc transduction. Treatment of cells with azidothymi-
dine (AZT) also inhibited VLP infection, indicating the require-
ment for reverse transcriptase. In addition, mutations of Gag late
domains or of viral protease, reverse transcriptase, and integrase
genes in the viral packaging plasmids abolished Luc transduction
(data not shown). These results indicated that the HIV-1 and
HTLV-1 vectors transduced target cells in coculture with no
background from the effector cells. Furthermore, cell-cell fusion
did not contribute to infection or reporter gene expression (see Fig.
S1 and Protocol S1).
To identify suitable target cells for coculture infection
experiments, we examined Luc transduction of established cell
lines and primary activated CD4
+ T cells by coculture with Jurkat
cells transfected with HTLV-1 vectors (Fig. 2B). T-cell lines, such
as Jurkat, JM, MOLT4, SupT1, and CEM174, yielded similar
levels of Luc activity 48 h after the start of coculture with Jurkat
Figure 2. Characteristics of the replication dependent vectors in coculture infections. (A) HTLV1-inLuc and HIV1-inLuc vectors were
transfected into Jurkat cells with respective packaging vectors and Env expression plasmids; transfected Jurkat cells were combined with an equal
number of Raji/CD4 cells 24 h later. Infection is expressed as relative light units (RLU) of luciferase activity, measured 48 h after cell mixing. Coculture
of Raji/CD4 cells with Jurkat cells transfected with wild type vectors is designated as control. The level of infection between Jurkat cells was
determined in cultures without Raji/CD4 cells (no Raji). In other cocultures, Jurkat cells transfected with reporter vectors but without Env-expression
plasmid (no Env) or without packaging plasmid (no pack) produced no Luc activity above background. Cotransfection of the viral vectors with a
dominant-negative VPS4A plasmid (VPSdn), which inhibits virus budding, or addition of the reverse transcriptase inhibitor azidotimidine (AZT 20 mm)
inhibited Luc transduction. (B) Jurkat cells were transfected with HTLV-1 packaging plasmid and HTLV1-inLuc reporter vector and then incubated
with an equal number of the indicated cells. Luc activity in the target cells was assayed 48 h after cell mixing. Luc activity was not detected in
activated human CD4
+ T cells from different donors in repeated experiments. Graphs represent the mean of at least three independent experiments
with error bars indicating standard deviations.
doi:10.1371/journal.ppat.1000788.g002
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compared to the other T-cell lines. Unexpectedly, and in repeated
attempts with cells from various donors, we were unable to detect
Luc activity after coculture of Jurkat effector cells with activated
human CD4
+ T cells. In parallel experiments, the same CD4
+ T
cells were efficiently transduced with cell-free HIV-1 VLPs. It is
presently unclear whether infection, provirus formation, or
subsequent reporter gene expression are inhibited during the
48 h of coculture of activated CD4
+ T cells with Jurkat effector
cells; we are currently examining the reasons for this inhibitory
effect. It was not surprising that HTLV-1 vectors transduced B-cell
and monocyte cell lines, as it is well known that HTLV-1 infects a
wide variety of cell types in vitro via Env interactions with
ubiquitously expressed receptor(s), GLUT-1, NP1, and heparan
sulfate proteoglycans [32,33,34]. In general, HTLV-1 transduc-
tion of B-cell lines appeared to be higher than the T-cell lines, with
Raji/CD4 cells giving the highest level of Luc activity of any cell
line tested. It is not clear yet whether the high level of Luc activity
detected in Raji/CD4 cells is due to specific interactions with
Jurkat cells that enhance virus transmission and replication, or that
Raji/CD4 cells support higher levels of reporter gene expression.
In addition to the high levels Luc transduction, we chose to use
Raji/CD4 cells in the following experiments for several reasons.
First, B-cells are natural targets for HTLV-1 infection in vivo and in
vitro [35,36,37,38,39]. Furthermore, B-cells were shown to form
conjugates (virological synapses) with HTLV-1-infected T cells in
PBMC cultures from HTLV-1-infected individuals [14]. Second,
while we recognize that B-cells are not natural targets for HIV-1
infection, Raji/CD4 cells can be infected by both HTLV-1 and
HIV-1 vectors for comparative analyses. Finally, Jurkat and Raji
cells have been used previously to study immunological synapse
formation [40,41], and in experiments described below, this
allowed us to determine whether forcing cells together via a
superantigen-induced synapse would enhance or inhibit virus
infection.
Role of the cytoskeleton in HTLV-1 and HIV-1 coculture
infection
To examine the role of cytoskeletal remodeling on single-cycle
infection with HTLV-1 and HIV-1 vectors in the Jurkat-Raji/
CD4 system, cocultures were treated with cytochalasin D (ChD) or
jasplakinolide (Jsp), which target actin polymerization/depolymer-
ization, or with nocodazole, which inhibits tubulin polymerization.
Because of the reversible effects of the inhibitors and the fact that
infection is measured 48 h after the start of coculture, both effector
and target cells were exposed to the drugs for the duration of the
experiment (Fig. 3). We observed that there was no significant
decrease in cell-free infection of inhibitor-treated Raji/CD4 target
cells with HTLV-1 and HIV-1 VLPs (data not shown). To control
for the effects of the inhibitors on VLP production in effector cells,
we measured Gag protein in cell culture supernatants at the end of
the coculture experiment by HTLV-1 p19 or HIV-1 p24 ELISA.
Figure 3 shows infectivity (Luc activity), Gag concentration in the
supernatant, and normalized infectivity (Luc activity divided by
Gag level) relative to untreated controls. The actin inhibitors, Jsp
and ChD, diminished VLP production by 45% and 14%
respectively with HTLV-1 vectors (Fig. 3A) and by 49% and
39% with HIV-1 vectors (Fig. 3B). For HIV-1 vectors, the
decrease in infection resulting from Jsp and ChD treatment could
be accounted for by the decrease in VLP production, because the
normalized infectivity was equal to or greater than the untreated
control. In contrast, the inhibition of infection with HTLV-1
vectors was significantly greater than the decrease in VLP
production, and the normalized infectivity was 3% and 5% of
untreated controls (Fig. 3A). Nocodozole had only a modest effect
on HTLV-1 VLP production (6% decrease) but had a significant
inhibitory effect on coculture infection (85% decrease) (Fig. 3A).
For HIV-1 vectors, nocodazole inhibited both VLP production
and infection, the normalized infectivity (60% compared to
untreated control) was not as severely affected as HTLV-1.
Together, the single-cycle replication data indicate that coculture
infections with HTLV-1 vectors were strongly dependant on
cytoskeletal remodeling, whereas infections with HIV-1 vectors
were much less so in this experimental setting. These results
suggest that the cell-free component of HIV-1 infection in Jurkat-
Raji/CD4 co-culture predominate, but do not exclude an
important role for cell-to-cell infectious transmission of HIV with
other effector-target cell combinations. In contrast, HTLV-1
infection appears to require cell-cell contact.
Differences in HTLV-1 and HIV-1 transmission in the
coculture infections
We next compared the relative efficiency of cell-free versus cell-
to-cell infection with HIV-1 and HTLV-1 vectors. Although VLP
Figure 3. Effects of cytoskeleton disrupting agents on coculture
infection with HTLV-1 and HIV-1 vectors. (A) Jurkat cells were
transfected with HTLV-1 vectors or (B) HIV-1 vectors (plus HTLV-1 Tax
expression plasmid) and then mixed with an equal number of Raji/CD4
cells. Cocultures were left untreated or treated for the duration of the
coculture with100 nMjasplakinolide(Jsp),5 mM cytochalasin D (ChD), or
5 mM nocodozole (nocod). Values for infection (RLU of Luc activity) and
Gag concentration in culture supernatants (Gag) are expressed as
percent relative to untreated controls. For HTLV-1 vectors, Luc activity
was 3.54610
5 RLU and Gag (p19) concentration was 1.18 ng per ml in
the untreated control. For HIV-1 vectors, Luc activity was 2.83610
5 RLU
and Gag (p24) concentration was 1.81 ng per ml in the untreated
control. Graphs represent the mean of at least three independent
experiments with error bars indicating standard deviations.
doi:10.1371/journal.ppat.1000788.g003
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1 vectors, infectious titers are quite different [42,43]. In order to
obtain sufficiently high infectious titers of HTLV-1 VLPs for cell-
free infection experiments, 293T cells were transfected with the
same viral vectors and at a ratio identical to those used in
transfection of Jurkat cells and luciferase transduction was
normalized relative to the amount of Gag in the filtered
supernatant (Fig. 4A). Infections in Jurkat-Raji/CD4 cocultures
were carried out as before, where infection is normalized to the
amount of Gag in the supernatant 48 h after mixing (Fig. 4A). For
HTLV-1 vectors, infectivity was at least 4 logs higher in coculture
infection compared with cell-free VLPs. In contrast, the infectivity
of HIV-1 vectors was only 2-fold higher in cocultures compared
with cell-free VLPs. These data are in agreement with the previous
experiments and suggest a cell-to-cell mode of infection with
HTLV-1 VLPs in Jurkat-Raji/CD4 cocultures, while cell free
transmission constitutes a significant component of HIV-1
infection in this system.
In the Jurkat-Raji/CD4 coculture system, infection is measured
48 h after cell mixing, as this is the time required for optimal
reporter gene expression. It would be desirable, however, to limit
the period of VLP transmission to the first few hours after the start
of coculture, as one would expect there to be significant differences
in the levels of infection at these early times that are related to the
mode of virus transmission. This can be accomplished by blocking
virus entry at various times after cell mixing with either anti-Env
neutralizing antibodies or antibodies that block virus receptors.
For the purposes of this experiment, it does not matter which type
of antibody is used, as it is important only to block infection after a
defined period of virus transmission (Fig. S2). Time-course of
transmission experiments, in which virus entry and infection were
blocked with antiserum to HTLV-1 Env or antibody to the CD4
receptor, are shown in Fig. 4B and 4C. Anti-HTLV-1 human
serum or anti-CD4 mAb were titrated to give greater than 95%
inhibition of infection; control serum or mAb did not inhibit Luc
transduction and neutralization of infection was specific for each
virus. When antibodies were added at the same time that cells
were combined (0 h), Luc transduction was inhibited by almost 2
orders of magnitude. For HTLV-1, levels of infection rose rapidly,
increasing by about 10-fold during the first 4 h, then began to
plateau after 6 h (Fig. 4B). In contrast, HIV-1 infection increased
only 2-fold by 4 h after the start of coculture (Fig. 4C). These
results indicate that the mechanisms of transmission of HTLV-1
and HIV-1 differ in this experimental system (see discussion
below); for HTLV-1 VLPs, cell-to-cell spread appears to be the
dominant mode of infection.
Effects of HTLV-1 Tax on the mechanism of VLP
transmission in Jurkat-Raji/CD4 cocultures
HTLV-1 Tax interacts with a variety of cellular proteins to alter
transcription, signal transduction, cell adhesion, and cytoskeletal
remodeling [44]. To determine whether Tax has an impact on
coculture infections, HTLV-1 packaging plasmids were used that
contain either a wild type (Tax
+) or a mutated tax gene (Tax
2); for
HIV-1 infections, cells were cotransfected with HIV-1 vectors plus
a Tax expression plasmid (Tax
+) or empty vector (Tax
2). We first
examined the effects of HTLV-1 Tax expression on the time
course of VLP transduction where infection was blocked with
neutralizing antisera at various times after the start of coculture
(Fig. 5A and B). With wt HTLV-1 vectors, Luc transduction
increased rapidly over the first several hours of coculture (Fig. 5A).
With the Tax
2 vector, the initial change in HTLV-1 infection was
significantly diminished and the time course resembled HIV-1
infection (Fig. 5A). When Tax was co-expressed with HIV-1
Figure 4. Differences in the mechanisms of transmission for
HTLV-1 and HIV-1 in Jurkat-Raji/CD4 cocultures. (A)C o m p a r -
ison of cell-free (CF) and coculture (CC) infection. Raji/CD4 cells were
infected with cell-free VLPs produced from transfected 293T cells or
by coculture with transfected Jurkat cells. Luc activity is normalized
relative to the amount of viral Gag protein in the supernatants. (B)
T h et i m ec o u r s eo fH T L V - 1c o c u l ture infection was examined by
blocking virus entry and infection with HTLV-1-infected human
plasma (filled squares) at the indicated times after mixing
transfected Jurkat cells and Raji/CD4 cells. Luc activity was measured
48 h after the start of coculture (0 h). For control infections, human
plasma from HIV-1-infected patients was used (open squares). (C)
Time course of HIV-1 coculture infection was examined by blocking
virus entry and infection as in (B) except that anti-CD4 mAb SIM.2
(open circles) was used to block entry and non-blocking anti-CD4
mAb SIM.4 was used as control (filled circles). Luc activity was
measured 48 h after the start of coculture (0 hr). These experiments
were performed at least 3 times; error bars depict standard
deviations.
doi:10.1371/journal.ppat.1000788.g004
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nearly reaching the levels obtained with wild type HTLV-1 vectors
(Fig. 5B). These results indicate that HTLV-1 Tax is a major
determinant of the difference observed in the mechanism of
HTLV-1 and HIV-1 transmission here. This is consistent with
known effects of Tax on the expression and activity of adhesion
proteins and activation of signal transduction pathways that may
cooperate to enhance virus infection and replication.
To determine whether Env plays a role in determining the
mechanism of virus transmission in coculture infections, we
examined pseudotyped VLPs (Fig. 5C). Unfortunately, HTLV-1
VLPs pseudotyped with HIV-1 Env were not infectious and HIV-
1 VLPs pseudotyped with HTLV-1 Env had very poor infectivity
(Fig. S3). These results may reflect differences in Gag and Env
trafficking between HTLV-1 and HIV-1, as we have previously
shown that HIV-1 and HTLV-1 Gag are targeted to different
plasma membrane microdomains for virion assembly in Jurkat
cells [40]. However, both HIV-1 and HTLV-1 VLPs can be
pseudotyped with VSV-G protein. Expression of Tax in Jurkat
cells boosted infection by about 5-fold for both HTLV-1 and HIV-
1 VLPs in Jurkat-Raji/CD4 cocultures (Fig. 5C). However, the
Tax-induced enhancement of infection was not seen when VLPs
were pseudotyped with VSV-G protein, suggesting that Tax elicits
specific cellular alterations that enhance infection only in
combination with a particular type of Env. We also examined
the effects of Tax expression in cocultures of transfected 293T cells
or HeLa-P4 cells (Fig. 5D). In this one-step transfection/infection
coculture system, transfected cells produce VLPs that infect
neighboring cells. Neither HTLV-1 nor HIV-1 VLP transduction
was enhanced by Tax in 293T cells or HeLa-P4 cells (Fig. 5D) or
in cell-free infections (data not shown). Together, these data
indicate that Tax-mediated enhancement of infection in cocultures
is dependent on cell type and on Env. Perhaps, Tax is not only
involved in the mobilization of Gag to the cell synapse, but also in
establishing crosstalk between certain Env and adhesion molecules
for their efficient membrane movement toward the site of cell-cell
contact.
A superantigen-induced immunological synapse does
not enhance cell-to-cell infection
It has been reported previously that HTLV-1 Tax induces
homotypic aggregation in various T-cell lines [45]. To determine
whether the ability of Tax to enhance infection in Jurkat-Raji/
CD4 cocultures was simply due to cell-cell aggregation, we
Figure 5. HTLV-1 Tax expression in Jurkat cells enhances coculture infection of Raji/CD4 cells with HIV-1 and HTLV-1 vectors. (A)
Time course coculture infection experiments were performed as in figure 4B except that Jurkat cells were transfected with either wt (Tax+)o r
mutated (Tax
2) HTLV-1 packaging vectors. (B) A coculture infection time course experiment was performed as in figure 4C except that Jurkat cells
were transfected with HIV-1 vectors with either a Tax-expression vector (Tax
+) or empty vector (Tax
2). (C) HIV-1 and HTLV-1 VLPs were pseudotyped
with VSV-G or their own Env and examined in Jurkat-Raji/CD4 coculture infection system with or without Tax expression. Infectivity is expressed as
Luc activity (RLU) relative to the amount of Gag protein in the culture medium at 48 h. (D) Human 293T cells or HeLa-P4 cells were transfected with
the same plasmids as in panel C. The medium was replaced the next day and the infection was allowed to develop until 48 h after transfection.
Infectivity is expressed relative to the concentration of Gag in the supernatant. All results represent the mean of at least three independent
experiments with standard deviations represented by error bars.
doi:10.1371/journal.ppat.1000788.g005
Cell-to-Cell Infection HTLV-1 HIV-1 inLuc
PLoS Pathogens | www.plospathogens.org 6 February 2010 | Volume 6 | Issue 2 | e1000788examined whether inducing a synapse between Jurkat cells and
Raji/CD4 cells would affect cell-to-cell infection. Staphylococcal
enterotoxin E (SEE) induces the formation of an immunological
synapse (IS) by binding to both the TCR on Jurkat T cells and
MHC-II on Raji B cells [46]. We used this system previously to
show that HTLV-1 Gag traffics with tetraspanin-enriched plasma
membrane microdomains to the IS [40]. Stable interaction
between Jurkat cells and Raji/CD4 cells was assayed by flow
cytometry (Fig. 6A). In the absence of Tax expression or SEE
treatment, about 20% of Jurkat cells fractionated with Raji/CD4
cells (Fig. 6A, left hand panels). Transduction of Jurkat cells with a
lentivirus vector expressing HTLV-1 Tax (approximately 85%
transduction efficiency) before mixing with Raji/CD4 cells
increased conjugate formation to 68%. When Raji/CD4 cells
were pretreated with SEE and mixed with Jurkat cells, 85% of
Jurkat cells were conjugated with Raji/CD4 cells (Fig. 6A, lower
right hand panel). Coculture of transfected Jurkat cells with Raji/
CD4 cells that had been pretreated with SEE revealed that
induction of an IS did not enhance HIV-1 or HTLV-1 VLP
infectivity, either in the presence or absence of Tax (Fig. 6B).
These results are in striking contrast to the enhancement of
infectivity by Tax, suggesting that Tax increases the expression or
activity of specific adhesion molecules and signaling pathways
necessary for efficient cell-to-cell infection.
Discussion
Our aim was to develop retroviral vectors that would make it
possible to directly quantify retroviral replication in cell-to-cell
virus transmission experiments. Retroviral reporter vectors have
greatly enhanced our understanding of the retrovirus infectious
cycle, but their utility has been limited primarily to cell-free
infection studies due to high levels of reporter gene expression in
VLP producer cells. The new reporter vectors, referred to here as
inLuc or inYFP vectors, rely on RNA splicing in the effector cell
and provirus formation in the target cell to activate reporter gene
expression. Considering the complex mechanisms that both HIV-
1 and HTLV-1 have evolved to regulate mRNA splicing and
transport, the system produces surprisingly clear results. There was
no signal from the reporter vector alone in transfected cells and
disrupting a viral structural or enzymatic function in the packaging
vector abolished reporter protein expression. These vectors are
ideally suited for studies of cell-to-cell infection in the coculture
setting. In previous studies of virus transmission from a transfected
or virus-infected effector cell to a target cell, infection was often
inferred by measuring viral protein transfer between cells by
microscopy, flow cytometry [11,12], or by the formation of
nascent reverse transcription products [6,7]. Hubner W. at al. [26]
beautifully demonstrated early and late stages of HIV cell-to-cell
transmission and target cell infection using 3D video microscopy of
replication competent fluorescent HIV clone. However, most of
the above methods require virus-infected rather than transfected
effector cells due to background problems associated with
transfected plasmid DNA. It is therefore difficult to analyze viral
mutants and pseudotyped virions. We believe that the vectors
described here will help to mitigate some of these problems and
enable future quantitative studies of cell-to-cell infection.
The new vectors were validated in coculture infections with
transfected Jurkat cells as the effectors, because these are well
characterized T-cells and have high transfection efficiency.
Clearly, it will be important to examine other effector cells,
particularly primary human cells, with these vectors in the future.
A variety of lymphoid and monocyte cell lines were examined as
targets in cocultures with Jurkat cells transfected with HTLV-1
vectors. All cell lines were susceptible to infection, but Raji/CD4
cells gave the highest levels of Luc activity. This was not due to
Figure 6. A superantigen-induced immunological synapse does not enhance infection with HIV-1 or HTLV-1 VLPs. (A) Conjugate
formation between Jurkat cells and Raji/CD4 cells was quantified by flow cytometry. One hour after mixing, cells were fixed and stained with anti-
CD3-FITC (Jurkat cells) and anti-HLA-DR-PE antibodies (Raji/CD4 cells); cell-cell conjugates are identified as double-positive signals. The basal level of
conjugate formation was approximately 20% (left hand panels). In the upper panels, Jurkat cells were transduced with lentivirus vectors encoding
GFP only (left) or Tax-IRES-GFP (right) 48 hrs before mixing with Raji/CD4 cells. In the lower panels, Raji/CD4 cells were untreated (left) or were pulsed
with SEE (right) prior to mixing with Jurkat cells. Typical Dot Plots from one of three experiments are presented. (B) Effects of SEE-induced synapse
formation on HIV-1 and HTLV-1 infection in Jurkat-Raji/CD4 cocultures. Luc activity is normalized relative to the amount of Gag in culture
supernatants at the end of infection. The histograms represent the mean of four independent experiments.
doi:10.1371/journal.ppat.1000788.g006
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not shown). It is possible but unlikely that the CMV promoter-
driven reporter gene is more active in Raji cells compared to other
cell lines, even other EBV-transformed B-cell lines. Alternatively,
higher levels of Luc transduction in Raji cells may reflect a unique
interaction between adhesion molecules on the surface of Raji cells
and Jurkat cells that enhances cell-to-cell infection. We are
currently examining these possibilities. Although Raji/CD4 cells
are not natural targets for HIV-1 infection, we believe that they do
provide an appropriate model system to study HTLV-1 cell-to-cell
infection, as B-cells are natural targets for HTLV-1 infection in vivo
and in vitro [35,36,37,38,39] and can form synapses with HTLV-1-
infected T lymphocytes in vitro [14]. While it is desirable to
examine cell-to-cell infection using primary T-cells as targets, we
have been unable to detect Luc transduction in cocultures of
transfected Jurkat T-cells and activated CD4
+ T-cells. This
appears to be due to a negative effect of the activated CD4
+ T-
cells on VLP expression in Jurkat cells during the 48 h coculture
infection, as the primary CD4
+ T-cells (from various donors) were
susceptible to infection with cell-free HIV-1 VLPs (D.M. and
D.D., unpublished observation).
Infections carried out with HTLV-1 vectors in Jurkat-Raji/CD4
coculture had all of the characteristics expected for cell-to-cell
infection. Infection was dependent on cytoskeletal remodeling, as
inhibitors of actin and tubulin abolished infectivity. The time
course of infection revealed rapid and efficient HTLV-1 VLP
transmission immediately after mixing effector and target cells,
and the difference in cell-free versus coculture infection was
consistent with cell-to-cell infection for HTLV-1. Thus, we believe
that this cell culture model system will be useful for examining the
cell and virus determinants of cell-to-cell infection for HTLV-1.
Relative to HTLV-1, HIV-1 VLPs appeared to be transmitted
efficiently as cell-free particles. However, the inhibitory effect of
the tubulin depolymerization agent nocodazole on HIV-1
coculture infection shows a cell-to-cell component of HIV
transmission in our experimental setting. The differences in
kinetics of HIV-1 coculture infection versus HTLV-1 infection
may also be due to the less efficient or not too rapid VS formation
between HIV producer cells and target cells. Thus, early after
Raji/CD4 cell addition, cell free infection may predominate, but
later transmission through the VS may be favored. The release of
HIV from the surface of producer cells needed for viral maturation
and recent demonstration of HIV endosomal fusion [47] may
influence the rate of infectious transmission. HTLV-1 Gag is
found to be processed inside the cells [40,48,49], so infectious
VLPs can be readily fused with plasma membrane and quickly
transfer the infection. HIV Jurkat-Raji/CD4 coculture infection
displays a high resistance to neutralizing mAbs (25–50 mg/ml for
80–95% inhibition in kinetics experiments versus 5–10 mg/ml for
cell-free infection (DM, DD unpublished observations), another
indication of cell mediated virus transfer. This is consistent with
previous reports of HIV cell-to-cell transmission being resistant to
broadly neutralizing Abs and patient serum [10,26,50]. Therefore,
to estimate cell-to-cell infection of HIV per se, the cell-free
component of infection should be eliminated experimentally or
subtracted from a total level of infectivity measured in cell
cocultures.
We showed that the HTLV-1 Tax protein is a major
contributor to the difference between HTLV-1 and HIV-1
infection in Jurkat-Raji/CD4 cocultures and that Tax significantly
enhanced HTLV-1 cell-to-cell infection. The positive effects of
Tax on HTLV-1 infection observed in the Jurkat-Raji/CD4
cocultures were not detected in 293T cells, indicating that Tax
enhances infection in a cell type-specific manner. Tax is known to
modulate many cellular functions, affecting the orientation and
activity of the microtubule organizing center (MTOC) [51], up-
regulating the expression of cell adhesion molecules such as
ICAM-1 [52], and modulating signal transduction pathways [44].
Furthermore, Tax has been observed to localize to an area in
infected T-cells near the interface with the target cell [51]. We
suspect that multiple activities of Tax may cooperate to enhance
cell-to-cell infection; examination of various Tax mutants, which
are defective for specific interactions with cellular proteins, may
help to identify critical Tax actions. The likelihood that Tax
induces formation of a specialized cell adhesion synapse for
efficient viral transmission is suggested by the result showing that a
superantigen-induced immunological synapse between Jurkat cells
and Raji/CD4 cells did not enhance cell-to-cell infection.
Although IS has similarity with VS, the formation of the SEE-
induced IS is inappropriate for VLP transmission. Recent reports
demonstrating that HIV Gag preferentially forms ring [23] or
wide ‘‘button’’ [26] like structures at VS, i.e. localizes in a
peripheral, not central, supramolecular adhesion complex of
synapse, further highlight the differences between IS and VS.
In summary, we have developed an experimental system,
which makes it possible to directly quantify cell-to-cell infection.
Results obtained with this system underscore the importance of
quantitative measurements to validate inferences based on
microscopic observations. It will be extremely interesting to
extend the experimental approach described here to other cell
types and, first of all, to primary human cells, and we are
optimizing transfection and coculture conditions for such
experiments.
Materials and Methods
Cells, antibodies, and reagents
Human cell lines Jurkat E6-1, JM, MOLT-4, SupT1, CEM174,
H9, AA-2, Ramos, U937 and THP-1 were obtained through the
AIDS Reference Reagent Program, Division of AIDS, NIAID,
NIH. Raji/CD4 cells [31] were from Vineet N. KewalRamani
(NCI-Frederick) and 729B cells were from Patrick Green (Ohio
State University). T-cell, B-cell and monocyte cell lines were
maintained in RPMI 1640 medium containing 10% fetal calf
serum. Primary human CD4+ T cells were prepared from
elutriated lymphocytes and grown in RPMI 1640 medium
containing 10% fetal calf serum and 100 U per ml of IL-2 after
activation with anti-CD28/anti-CD3 beads as described previous-
ly [53]. Human kidney 293T cells, Hela-P4 cells [54] (Eric Freed,
NCI-Frederick), hybridomas anti-human CD4 clone SIM.2 and
SIM.4, anti-HIV-1 gp120 clone 902 (NIH AIDS Research &
Reference Reagent Program) were grown in Dulbecco’s modified
Eagle’s medium (DMEM) containing 10% fetal calf serum. IgG
from hybridoma supernatants were purified using protein A (for
IgG1) or protein G (for IgG2b) HiTrap columns (GE Healthcare),
then desaulted using PD-10 column (GE Healthcare), reconstitut-
ed in Dulbecco PBS without Ca and Mg and sterilized by filtration
through 0.45 micron low protein-binding filters (Millipore). The
anti-human CD3 clone UCHT1 (unconjugated, FITC-conjugat-
ed, or APC-conjugated) and anti-human HLA-DR clone TU36
and clone G46-6 (conjugated with PE) mAbs were from BD
Pharmingen. Goat anti-mouse Alexa 546 secondary antibody was
from Molecular Probes. Inactivated plasma from HTLV-1-
positive patients was from Scripps Laboratories. Jasplakinolide
was from Molecular Probes; cytochlasin D was from Calbiochem;
azidothymidine and nocodozole were from Sigma. Staphylococcal
enterotoxin E (SEE) was purchased from Toxin Technology
(Sarasota, Florida).
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The HTLV-1 packaging plasmid pCMVHT1-M expresses the
full-length HTLV-1 genome and pCMVHT1M-DEnv expresses
all HTLV-1 gene products except Env [42]. The HTLV-1
packaging plasmids, pCMVHT1M-Tax9Q and pCMVHT1M-
DEnv-Tax9Q are Tax-minus due to a single nucleotide change
creating a stop codon in place of the glutamine at Tax codon 9.
The HIV-1 packaging plasmid pCMVD8.2R expresses all HIV-1
proteins except Env [55]. pCMV-HT1Env and pCMV-VSVG
express HTLV-1 Env and VSV-G protein, respectively. The HIV-
1 Env expression plasmid pIIINL-4env [56] was obtained from
Eric Freed (NCI-Frederick). The HTLV-1 Tax expression plasmid
pCMV-Tax1C was described [57]. The dominant negative form
of human VPS4A protein was expressed from pGFP-VPS4A-
E223Q [58]. Lentivirus vectors for transduction of HTLV-1 Tax
and GFP were constructed by subcloning HTLV-1 Tax-IRES-
GFP or IRES-GFP cassettes into pUCHR transfer vector to give
pUCHR-TaxIRGFP and pUCHR-IRGFP, respectively.
New, replication-dependent HTLV-1 reporter vectors were
made from pHTC-GFPLuc [42] by first replacing the U3 region
in the 59LTR with CMV promoter, joined at the TATA box. The
reporter cassette within the vector was replaced with a cassette
from the plasmid pKS99gfp (from John Moran, University of
Michigan), containing CMV promoter, gfp gene (with c-globin
intron), and TK polyA signal [29]; this cassette is oriented in the
opposite direction relative to viral vector transcription, but the
intron is oriented in the sense direction. Finally, the gfp gene was
replaced with either luciferase or yfp genes containing a c-globin
intron to give pCRU5HT1-inLuc and pCRU5HT1-inYFP,
respectively (which we refer to as HTLV1-inLuc and HTLV1-
inYFP). HIV-1 replication-dependent reporter vectors, pUCHR-
inLuc and pUCHR-inYFP were constructed from pUCHR-
GFPLuc by replacing the reporter cassette with the respective
cassettes from HTLV-1 vectors described above, and are referred
to here as HIV1-inLuc and HIV1-inYFP.
Transfections and infections
Jurkat cells, 293T cells and Hela-P4 cells were transfected with
TransITH-Jurkat, TransITH-293 (Mirus), or FuGENE6 (Roche)
transfection reagents, respectively, according to the manufacturers’
instructions. Cell-free infection assays were performed essentially
as described previously [59]. VLP concentrations were determined
by HTLV-1 p19 or HIV-1 p24 antigen capture ELISA
(Zeptometrix). Coculture infections were initiated by transfecting
Jurkat cells (10
6 cells in 1 ml) with 0.6 mg of inLuc vector DNA,
0.4 mg of packaging plasmid DNA, and 0.1 mg of Env-expression
plasmid DNA (for env-minus packaging plasmids) or empty vector
DNA (for env-positive packaging plasmids). After 24 h, cells were
washed twice with PBS and 10
6 Jurkat cells were mixed with an
equal number of Raji/CD4 target cells in 5 ml of medium. Cells
were collected 48 h later, extracted in GLO lysis buffer (Promega),
and Luc activity was measured using Promega luciferase reagent
and Lumat LB9501 luminometer (Berthold). For antibody
blocking experiments, HTLV-1-positive human plasma was
heated at 56uC for 30 min. to inactivate complement and added
to HTLV-1 infections at 1/100 dilution; similarly treated HIV-1-
positive human plasma was used as a control for HTLV-1
infections. For HIV-1 infections, anti-gp120 902 mAb at a
concentration 50 mg/ml or anti-CD4 SIM.2 mAb 25 mg/ml was
added to cells; non-blocking anti-CD4 SIM.4 mAb at a similar
concentration was used as control. Immunological synapse
formation was induced by pulsing Raji/CD4 cells (10
7 cells per
ml in PBS) with 10 mg/ml of SEE for 1 hr; cells were washed 4
times with PBS, and combined with Jurkat cells at a 1:1 ratio.
FACS analysis of cell conjugate formation
Untreated or SEE-treated Raji/CD4 cells (10
7 per ml) were
mixed with an equal number of Jurkat cells in complete medium
for 1 hr. After centrifugation, cells were fixed with 4%
paraformaldehyde for 10 min, washed with PBS, stained with
anti-CD3-FITC plus anti-HLA-DR-PE Abs for 30 min, and
analyzed by flow cytometry. Cell conjugates were expressed as the
percentage of double positive cells in the total Jurkat cell
population. To determine the effects of HTLV-1 Tax expression
on adhesion of Jurkat cells to Raji/CD4 cells, Jurkat cells were
transduced with cell-free VLPs that were generated by transfecting
293T cells with pUCHR-TaxIRGFP or pUCHR-IRGFP plus
pCMVD8.2R and pCMV-VSVG. At 48 hrs after transduction,
Jurkat cells (greater than 85% GFP-positive) were washed and
mixed with Raji/CD4 cells at a 1:1 ratio for 1 hr. Cell conjugate
formation was determined as described above.
Supporting Information
Figure S1 Morphological and phenotypic analysis of infected
cells using inYFP vectors. (A) FACS analysis of infection events.
Jurkat cells were transfected with inYFP vectors and respective
packaging plasmids and cocultured with Raji/CD4 cells in the
presence or absence of 20 mm AZT. YFP-positive cells were
enumerated by flow cytometry 48 hr after infection; dead cells
were excluded by propidium iodide (PI) staining. (B) Aliquots of
cells were removed from the samples described above 48 hr after
infection and placed on glass coverslips. Cells were fixed and
stained with anti-HLA-DR antibody to mark Raji/CD4 cells (red),
with DAPI to stain nuclei (blue), or with anti-CD3 antibody to
stain Jurkat cells (not shown). Cells were analyzed by fluorescent
deconvolution microscopy; typical fields are presented as optical
sections through the middle of cells. Arrows indicate infected,
YFP-positive cells (green). (C) YFP-positive cells from two slides for
each virus were counted and categorized according to cell type
and morphology. YFP-positive cells were generally mononuclear;
i.e. single Jurkat cells or single Raji/CD4 cells. Rarely, a YFP-
positive Raji/CD4 cell was observed in the process of fusion with a
large multinucleated syncytium (fusing Raji) or a small region of a
giant HLA-DR-positive cell displayed YFP fluorescence (giant
fused cells DR
+).
Found at: doi:10.1371/journal.ppat.1000788.s001 (1.13 MB TIF)
Figure S2 Time course of HIV-1 entry block by antibodies to
Env or CD4. Mouse monoclonal antibodies, produced in
hybridomas 902 (anti-gp120) and SIM.2 (anti-hCD4) were
purified and concentrated, as described in method section, then
titrated to give at least 85% inhibition of HIV-1 infection with
902 mAb and greater than 95% inhibition with SIM.2 mAb. To
evaluate the kinetics of infection, at the times indicated in the
figure mAbs were added to cocultures of Jurkat and Raji/CD4
cells (where 0 hr marks the time when cells were mixed).
Luciferase activity was then measured 48 hr after the start of
coculture. The mean of three independent experiments with
standard deviations shown with error bars are presented. As
demonstrated on the figure, either Ab against the Env (filled
squares) or CD4 receptor (open squares) efficiently and similarly
inhibited HIV-1 replication in a slow rate manner. Neither SIM.2
nor 960 mAbs inhibited HTLV-1 cell-to-cell infection (data are
not shown), confirming the specificity of blocking.
Found at: doi:10.1371/journal.ppat.1000788.s002 (0.05 MB TIF)
Figure S3 Coculture infectivity of HIV-1 and HTLV-1 VLPs
are affected differently by Env pseudotyping. Jurkat cells
transfected with inLuc reporter vector, Env-minus packaging
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plasmids were cocultured with Raji/CD4 cells. Infectivity was
measured by luciferase assay 48 hr after infection. (A) HTLV-1
VLPs were pseudotyped with HTLV-1 Env (squares), HIV-1 Env
(triangles), or VSV-G protein (circles). (B) HIV-1 VLPs were
pseudotyped with HTLV-1 Env (squares), HIV-1 Env (triangles),
or VSV-G protein (circles). Infectivity is expressed as luciferase
activity (RLU) normalized to the amount of Gag protein in the
supernatant at the end of infection. The data represent the mean
of at least of three independent experiments with error bars
indicating standard deviation.
Found at: doi:10.1371/journal.ppat.1000788.s003 (0.12 MB TIF)
Protocol S1 FACS analysis and immunofluorescent microscopy
of infected cells.
Found at: doi:10.1371/journal.ppat.1000788.s004 (0.03 MB
DOC)
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